Operator of a genomic medicine delivery company intended to bridge the gap between genome technology and current medical practice. The company connects individuals and health care providers to genetic experts, providing a genetic assessment to individuals regarding the benefits of testing and creating a personalized clinical action plan, enabling patients to make informed treatment decisions at low costs and medical practitioners to accelerate disease diagnosis.
Developer and manufacturer of comprehensive genomic profiling products intended to help physicians make more informed care decisions. The company offers a comprehensive genomic profiling analysis of the tumour genome to identify clinically relevant alterations, thereby potentially expanding patients' treatment options.